PubRank

Naohito Fujishima

Author PubWeight™ 26.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008 1.88
2 Late-onset fatal Epstein-Barr virus-associated hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia. Int J Hematol 2006 1.38
3 Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse. Haematologica 2010 1.23
4 Diagnosis and management of acquired pure red cell aplasia. Hematol Oncol Clin North Am 2009 1.16
5 Dynamics of human erythroblast enucleation. Int J Hematol 2008 1.11
6 Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica 2008 1.04
7 Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol 2009 1.00
8 Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia. J Hum Genet 2010 0.97
9 TCRalphabeta repertoire diversity of human naturally occurring CD4+CD25+ regulatory T cells. Immunol Lett 2005 0.92
10 Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 2007 0.92
11 Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms. Clin Exp Nephrol 2011 0.89
12 Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells. Int J Hematol 2011 0.88
13 Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma. Intern Med 2008 0.87
14 Successful treatment of necrotizing fasciitis in an upper extremity caused by Clostridium perfringens after bone marrow transplantation. Intern Med 2011 0.84
15 Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome. Nephrol Dial Transplant 2005 0.83
16 Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants. Eur J Clin Pharmacol 2013 0.82
17 Cytomegalovirus-associated granulomatous gastritis after cord blood transplantation for acute myeloid leukemia. Int J Hematol 2007 0.82
18 A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells. Exp Hematol 2011 0.82
19 Contribution of complementarity-determining region 3 of the T-cell receptor Vdelta2 chain to the recognition of aminobisphosphonates by human gammadelta T-cells. Int J Hematol 2004 0.81
20 Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. Anticancer Drugs 2013 0.80
21 False-positive human immunodeficiency virus antibody test and autoimmune hemolytic anemia in a patient with angioimmunoblastic T-cell lymphoma. Intern Med 2011 0.79
22 A case of intravascular large B-cell lymphoma of the cutaneous variant: the first case in Asia. Int J Hematol 2009 0.79
23 Influence of UGT1A1 6, 27, and 28 polymorphisms on nilotinib-induced hyperbilirubinemia in Japanese patients with chronic myeloid leukemia. Drug Metab Pharmacokinet 2014 0.78
24 May-Hegglin anomaly developing myelodysplasia and acute myeloid leukemia. Int J Hematol 2004 0.77
25 Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission. Clin Lymphoma Myeloma Leuk 2012 0.77
26 Successful autologous peripheral blood stem cell transplantation using thiotepa in a patient with systemic sclerosis and cardiac involvement. Tohoku J Exp Med 2006 0.76
27 Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha. Int J Hematol 2009 0.76
28 Monitoring the expression profiles of doxorubicin-resistant K562 human leukemia cells by serial analysis of gene expression. Int J Hematol 2004 0.76
29 Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34(+) cells with granulocyte colony-stimulating factor and tumor necrosis factor-alpha. Int J Hematol 2008 0.76
30 Relationship between CYP2C19 phenotype using the voriconazole-to-voriconazole N-oxide plasma concentration ratio and demographic and clinical characteristics of Japanese patients with different CYP2C19 genotypes. Ther Drug Monit 2017 0.75
31 [Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome]. Rinsho Ketsueki 2012 0.75
32 [Case report; Fibrinoid necrotizing angiitis of the gall bladder in a patient with systemic lupus erythematosus]. Nihon Naika Gakkai Zasshi 2012 0.75
33 Treatment of multiple myeloma in Akita: features and outcomes in the era of novel agents. J Clin Exp Hematop 2014 0.75
34 Fatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma. J Infect Chemother 2011 0.75
35 Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder. Int J Hematol 2007 0.75
36 [Anemia: From Basic Knowledge to Up-to-Date Treatment. Topics: VI. Pathophysiology and management of aplastic anemia and pure red cell aplasia]. Nihon Naika Gakkai Zasshi 2015 0.75
37 A limited sampling model to estimate exposure to lenalidomide in multiple myeloma patients. Ther Drug Monit 2014 0.75
38 Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient. Clin Chim Acta 2011 0.75
39 Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia. Int J Clin Oncol 2012 0.75
40 CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia. Immunol Lett 2012 0.75
41 [Pathophysiology and treatment of large granular lymphocyte leukemia-associated pure red cell aplasia]. Rinsho Ketsueki 2010 0.75
42 Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate. Int J Hematol 2010 0.75